[1]
|
Screening of Translocation Ets-Leukemia-Acute-Myeloid-Leukemia-1 Fusion Gene and Expression Pattern of Multidrug Resistance Protein Protein in Children with Acute Lymphoblastic Leukemia
Journal of Biomaterials and Tissue Engineering,
2022
DOI:10.1166/jbt.2022.2864
|
|
|
[2]
|
Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
Frontiers in Pharmacology,
2021
DOI:10.3389/fphar.2021.771487
|
|
|
[3]
|
Pharmacogenomics insights into precision pediatric oncology
Current Opinion in Pediatrics,
2021
DOI:10.1097/MOP.0000000000001065
|
|
|
[4]
|
Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms22115504
|
|
|
[5]
|
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Genome Medicine,
2021
DOI:10.1186/s13073-021-00920-z
|
|
|
[6]
|
Pharmacogenomics insights into precision pediatric oncology
Current Opinion in Pediatrics,
2021
DOI:10.1097/MOP.0000000000001065
|
|
|
[7]
|
Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells
Molecules,
2020
DOI:10.3390/molecules25112517
|
|
|
[8]
|
Characterization of the kinetic cycle of an ABC transporter by single-molecule and cryo-EM analyses
eLife,
2020
DOI:10.7554/eLife.56451
|
|
|
[9]
|
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Cell Death & Disease,
2019
DOI:10.1038/s41419-019-1593-2
|
|
|
[10]
|
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Cell Death & Disease,
2019
DOI:10.1038/s41419-019-1593-2
|
|
|
[11]
|
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Cell Death & Disease,
2019
DOI:10.1038/s41419-019-1593-2
|
|
|
[12]
|
A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells
Molecules,
2018
DOI:10.3390/molecules23123264
|
|
|
[13]
|
miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
Oncotarget,
2017
DOI:10.18632/oncotarget.17677
|
|
|
[14]
|
MRP1 and its role in anticancer drug resistance
Drug Metabolism Reviews,
2015
DOI:10.3109/03602532.2015.1105253
|
|
|